PYC Therapeutics (ASX:PYC) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is PYC Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PYC Therapeutics's Free Cash Flow for the six months ended in Dec. 2023 was A$-7.12 Mil. PYC Therapeutics's Revenue for the six months ended in Dec. 2023 was A$0.00 Mil. Therefore, PYC Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, PYC Therapeutics's current FCF Yield % is -5.71%.

The historical rank and industry rank for PYC Therapeutics's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of PYC Therapeutics was -68.41%. The lowest was -490.75%. And the median was -333.55%.

ASX:PYC's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -145.32
* Ranked among companies with meaningful FCF Margin % only.

PYC Therapeutics FCF Margin % Historical Data

The historical data trend for PYC Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PYC Therapeutics FCF Margin % Chart

PYC Therapeutics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

FCF Margin %

Get a 7-Day Free Trial

PYC Therapeutics Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of PYC Therapeutics's FCF Margin %

For the Biotechnology subindustry, PYC Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PYC Therapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PYC Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PYC Therapeutics's FCF Margin % falls into.

PYC Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PYC Therapeutics's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-24.913	/	0
	=	%

PYC Therapeutics's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-7.118	/	0
	=	%

PYC Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of PYC Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

PYC Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PYC Therapeutics Ltd (ASX:PYC) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Verdun Street, Harry Perkins Institute of Medical Research, Nedlands, Perth, WA, AUS, 6009

Website

https://www.pyctx.com

PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company's drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.

PYC Therapeutics Headlines

No Headlines